Evidence map›Paper›PMID 40029563›Full record

ReviewTissue engineering and regenerative medicine2025

Advances and Challenges of Tissue Vascular Scaffolds and Supercritical Carbon Dioxide Technology in Cardiovascular Diseases.

Horng-Ta Tseng, Yi-Wen Lin, Shih-Ying Sung, Yi-Ting Tsai, Chen-Wei Liu, Po-Shun Hsu, Chien-Sung Tsai, Feng-Yen Lin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Tissue engineering and regenerative medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Horng-Ta TsengTaipei Heart Institute, Taipei Medical University, Taipei, 11031, Taiwan.
Yi-Wen LinTaipei Heart Institute, Taipei Medical University, Taipei, 11031, Taiwan.
Shih-Ying SungDivision of Cardiovascular Surgery, Tri-Service General Hospital, Defense Medical Center, Taipei, 11490, Taiwan.
Yi-Ting TsaiDivision of Cardiovascular Surgery, Tri-Service General Hospital, Defense Medical Center, Taipei, 11490, Taiwan.
Chen-Wei LiuDepartment of Basic Medical Science, College of Medicine, University of Arizona, Phoenix, AZ, 85721, USA.
Po-Shun HsuDivision of Cardiovascular Surgery, Tri-Service General Hospital, Defense Medical Center, Taipei, 11490, Taiwan.
Chien-Sung TsaiTaipei Heart Institute, Taipei Medical University, Taipei, 11031, Taiwan.
Feng-Yen LinTaipei Heart Institute, Taipei Medical University, Taipei, 11031, Taiwan. g870905@tmu.edu.tw.ORCID http://orcid.org/0000-0002-4939-2899

Funding

Ministry of Science and Technology, Taiwan NSTC 113-2320-B-038-066Ministry of Science and Technology, Taiwan NSTC 113-2635-B-A49-001Tri-Service General Hospital, Taipei, Taiwan TSGH-C01-113028
6 · The paper itself

Abstract

backgroundAtherosclerosis often leads to ischemic heart disease and peripheral artery disease. Traditional revascularization technique such as bypass grafting using autologous vessels are commonly employed. However, limitations arise when patients lack suitable grafts due to underlying diseases or previous surgeries, prompting the need to substitute vessel grafts. Due to the high biocompatibility of decellularized products (grafts or scaffolds) prepared using supercritical carbon dioxide (ScCO

methodThis review was compiled by searching relevant references on PubMed database (before June 2024) based on selected key words and specific terms.

resultsScCO

conclusionScCO

Indexed as

Blood Vessel ProsthesisCarbon DioxideCardiovascular DiseasesTissue EngineeringTissue ScaffoldsAnimalsHumansCarbon DioxideCardiovascular diseaseSupercritical carbon dioxideTissue vascular scaffolds

Identifiers

PMID40029563
PMCPMC11926293

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.